OWH’s effectiveness study, which enrolled 120 patients, is gathering information on how safe and efficacious PMIM mono-therapy for VL is at a regional level. The study will also
With the termination of the agreement, Abbott will have to provide certain forms of transition assistance to Emergent for a certain period of time and Emergent will retain
The findings were the result of research partnership between Alnylam and Medtronic and supported by CHDI. The results demonstrated that a small interfering RNA (siRNA) targeting huntingtin gene,
Each capsule within the Mega 2000 product includes 45 essential vitamins and minerals. These essential vitamins and minerals are expected to provide women with a complete balance to
Ventrus Biosciences has licensed the North American rights to diltiazem hydrochloride cream from SLA Pharma. Initial top-line data from the randomized, double-blind study is expected to be available
The primary endpoints of the human trial for GLPG0974 will be to determine the pharmacokinetics and to evaluate biomarker effects of this candidate drug. The placebo-controlled, double-blind, single
Financial terms of the agreement include an upfront fee, clinical and regulatory milestone payments, and royalties on sales. Under the terms of the agreement, CJ CheilJedang is responsible
Under future technical and commercial agreements, Angel will utilize its GMP facility at Cramlington to expedite and optimize the expression systems provided by TransGenRx. TransGenRx chief scientific officer
Sygnature and Cyprotex will extend their collaborative sales and marketing initiative to provide discovery chemistry/ADME-Tox/DMPK service to accelerate their clients’ drug discovery projects into development. Cyprotex CEO Anthony
The trial has recruited patients from 36 centers across Europe. This double blind trial is comparing two doses of TB-402 (25mg and 50mg), given as a single intravenous
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.